Henry Schein, Inc. (NASDAQ:HSIC) Short Interest Update

Henry Schein, Inc. (NASDAQ:HSIC) was the target of a large drop in short interest in March. As of March 31st, there was short interest totalling 5,500,000 shares, a drop of 6.8% from the March 15th total of 5,900,000 shares. Currently, 4.3% of the company’s stock are sold short. Based on an average daily volume of 1,140,000 shares, the days-to-cover ratio is currently 4.8 days.

Analyst Ratings Changes

Several brokerages recently commented on HSIC. Piper Sandler lifted their target price on shares of Henry Schein from $78.00 to $86.00 and gave the stock an “overweight” rating in a report on Monday, February 26th. Leerink Partnrs restated a “market perform” rating on shares of Henry Schein in a research report on Monday, February 26th. SVB Leerink began coverage on shares of Henry Schein in a research report on Monday, February 26th. They issued a “market perform” rating and a $78.00 price target on the stock. Evercore ISI raised their price target on shares of Henry Schein from $79.00 to $83.00 and gave the stock an “in-line” rating in a research report on Wednesday, February 28th. Finally, Barrington Research raised their price target on shares of Henry Schein from $82.00 to $90.00 and gave the stock an “outperform” rating in a research report on Wednesday, February 28th. One research analyst has rated the stock with a sell rating, six have issued a hold rating and five have assigned a buy rating to the company’s stock. According to data from MarketBeat, Henry Schein currently has an average rating of “Hold” and an average target price of $81.09.

Insider Activity

In other news, CEO Bradford C. Connett sold 6,430 shares of the firm’s stock in a transaction on Wednesday, March 20th. The shares were sold at an average price of $74.28, for a total transaction of $477,620.40. Following the transaction, the chief executive officer now owns 73,108 shares in the company, valued at approximately $5,430,462.24. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In related news, Vice Chairman James P. Breslawski sold 2,907 shares of Henry Schein stock in a transaction on Monday, March 18th. The shares were sold at an average price of $74.37, for a total value of $216,193.59. Following the transaction, the insider now owns 209,562 shares in the company, valued at approximately $15,585,125.94. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Bradford C. Connett sold 6,430 shares of Henry Schein stock in a transaction on Wednesday, March 20th. The stock was sold at an average price of $74.28, for a total transaction of $477,620.40. Following the completion of the transaction, the chief executive officer now owns 73,108 shares in the company, valued at approximately $5,430,462.24. The disclosure for this sale can be found here. 1.14% of the stock is owned by insiders.

Hedge Funds Weigh In On Henry Schein

Institutional investors have recently modified their holdings of the stock. McGlone Suttner Wealth Management Inc. bought a new position in shares of Henry Schein in the fourth quarter worth about $39,000. Baystate Wealth Management LLC lifted its holdings in Henry Schein by 2,500.0% in the third quarter. Baystate Wealth Management LLC now owns 520 shares of the company’s stock valued at $39,000 after buying an additional 500 shares during the period. Neo Ivy Capital Management acquired a new position in Henry Schein in the third quarter valued at approximately $46,000. Covestor Ltd lifted its holdings in Henry Schein by 88.4% in the first quarter. Covestor Ltd now owns 861 shares of the company’s stock valued at $75,000 after buying an additional 404 shares during the period. Finally, Harbour Investments Inc. lifted its holdings in Henry Schein by 27,725.0% in the fourth quarter. Harbour Investments Inc. now owns 1,113 shares of the company’s stock valued at $84,000 after buying an additional 1,109 shares during the period. 96.62% of the stock is owned by institutional investors.

Henry Schein Price Performance

NASDAQ:HSIC traded down $0.88 on Wednesday, reaching $70.34. The stock had a trading volume of 182,775 shares, compared to its average volume of 1,100,274. The company has a market capitalization of $9.04 billion, a P/E ratio of 22.61, a price-to-earnings-growth ratio of 1.75 and a beta of 0.87. Henry Schein has a 1-year low of $60.01 and a 1-year high of $85.39. The company has a quick ratio of 1.00, a current ratio of 1.67 and a debt-to-equity ratio of 0.45. The stock has a fifty day moving average price of $74.63 and a 200-day moving average price of $72.52.

Henry Schein (NASDAQ:HSIC) last announced its earnings results on Tuesday, February 27th. The company reported $0.66 earnings per share for the quarter, missing analysts’ consensus estimates of $0.70 by ($0.04). Henry Schein had a return on equity of 14.03% and a net margin of 3.37%. The company had revenue of $3.02 billion during the quarter, compared to the consensus estimate of $3 billion. During the same period in the prior year, the firm posted $1.21 earnings per share. The company’s revenue was down 10.5% on a year-over-year basis. Research analysts forecast that Henry Schein will post 5.07 EPS for the current year.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, physician practices, ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.